seroprevalence of MMR and varicella immunity among adolescence and young adult SEROPREVALENCE MEASLES MUMPS RUBELLA VARICELLA VACCINE IMMUNITY ADOLESCENSE YOUNG ADULTS
Conditions
Interventions
participants age 13-20 years on the date of study,participants age 21-30 years on the date of study,participants age 31-39 years on the date of study
Other,Other,Other
age 13-20,age 21-30,age 31-39
Sponsors
Mahidol University MTCM. Research funding 2022
Eligibility
Sex/Gender
All
Age
13 Years to 39 Years
Inclusion criteria
Inclusion criteria: - Thai nationality - Age between 13 - 39 years old at the time of hospital visit - Visiting hospital for blood testing one or more of any followings; measles, mumps, rubella, or varicella between 2018-2021
Exclusion criteria
Exclusion criteria: - Immunity checking after MMR or varicella vaccination - Unable to determine date of birth
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| seropositive rate at the time of hospital visit ELISA method | — |
Secondary
| Measure | Time frame |
|---|---|
| factors associated with seropositive rate at the time of hospital visit medical record review | — |
Countries
Thailand
Contacts
Public ContactSajikapon Kludkleeb
Mahidol University
Outcome results
None listed